Cost-effectiveness analysis of supervised exercise training in men with prostate cancer previously treated with radiation therapy and androgen-deprivation therapy

- Edmunds, Kim, Reeves, Penny, Tuffaha, Haitham, Scuffham, Paul, Galvão, Daniel A., Newton, Robert U., Jones, Mark, Spry, Nigel, Taaffe, Dennis R., Joseph, David, Chambers, Suzanne K.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

- Denham, James W., Joseph, David, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Matthews, John, Atkinson, Chris, Tai, Keen-Hun, Christie, David, Kenny, Lizbeth, Turner, Sandra, Gogna, Nirdosh Kumar, Diamond, Terry, Delahunt, Brett, Oldmeadow, Chris, Attia, John, Steigler, Allison

Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the Breast International Group 02-98 Trial

- Zeidan, Youssef, Habib, Joyce, Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Joseph, David, Crown, John, Piccart-Gebhart, Martine, Francis, Prudence, Ameye, Lieveke, Paesmans, Marianne, de Azambuja, Evandro, Gelber, Richard, Campbell, Ian, Nordenskjold, Bo, Gutierez, Jorge, Anderson, Michael

Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer

- Taaffe, Dennis R., Buffart, Laurien M., Newton, Robert U., Spry, Nigel, Denham, James, Joseph, David, Lamb, David, Chambers, Suzanne K., Galvão, Daniel A.

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial

- Cormie, Prue, Galvão, Daniel A., Spry, Nigel, Joseph, David, Chee, Raphael, Taaffe, Dennis R., Chambers, Suzanne K., Newton, Robert U.

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR

- Galvão, Daniel A., Spry, Nigel, Denham, James, Taaffe, Dennis R., Cormie, Prue, Joseph, David, Lamb, David S., Chambers, Suzanne K., Newton, Robert U.

Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study

- Cormie, Prue, Galvão, Daniel A., Spry, Nigel, Joseph, David, Taaffe, Dennis R., Newton, Robert U.

Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies

- Cormie, Prue, Chambers, Suzanne K., Hamilton, Kyra, Galvão, Daniel A., Newton, Robert U., Gardiner, Robert A., Spry, Nigel, Taaffe, Dennis R., Joseph, David, Hamid, M. Akhlil, Chong, Peter, Hughes, David

Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy

- Wall, Bradley A., Galvão, Daniel A., Fatehee, Naeem, Taaffe, Dennis R., Spry, Nigel, Joseph, David, Newton, Robert U.

Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer

- Buffart, Laurien M., Galvão, Daniel A., Chinapaw, Mai J., Brug, Johannes, Taaffe, Dennis R., Spry, Nigel, Joseph, David, Newton, Robert U.

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

- Denham, James W., Steigler, Allison, Wynne, Chris, Lamb, David S., Tai, Keen-Hun, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Turner, Sandra, North, John, Christie, David

Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?

- Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Cormie, Prue, Chambers, Suzanne K., Gardiner, Robert A., Shum, David H. K., Joseph, David, Galvao, Daniel A.

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

- Denham, James W., Wilcox, Chantelle, Gogna, Nirdosh Kumar, Kenny, Lizbeth, Duchesne, Gillian, Delahunt, Brett, McElduff, Patrick, Joseph, David, Spry, Nigel A., Lamb, David S., Tai, Keen-Hun, Matthews, John, Atkinson, Chris, Turner, Sandra, Christie, David

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

- Ngan, Samuel Y., Burmeister, Bryan, McKendrick, Joseph, Leong, Trevor, Hartopeanu, Cris, Zalcberg, John, Mackay, John, Fisher, Richard J., Solomon, Michael, Goldstein, David, Joseph, David, Ackland, Stephen P., Schache, David, McClure, Bev, McLachlan, Sue-Anne

Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer

- Denham, James W., Wilcox, Chantelle, Gogna, Nirdosh Kumar, Ebert, Martin, Delahunt, Brett, McElduff, Patrick, Joseph, David, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizabeth, Tai, Keen-Hun

Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: data from the TROG 96.01 trial

- Steigler, Allison, Denham, James W., Tai, Keen-Hun, Wynne, Chris, Lamb, David S., Spry, Nigel A., Joseph, David, Matthews, John, Atkinson, Chris, Turner, Sandra, North, John, Christie, David

A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial

- Lamb, David S., Denham, James W., D'Este, Catherine, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Duchesne, Gillian, Ebert, Martin, Steigler, Allison, Delahunt, Brett

Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response

- Galvao, Daniel A., Taaffe, Dennis R., Spry, Nigel, Joseph, David, Newton, Robert U.